drugset / Trial / NCT01274663
A Study Of PF-05175157 In Healthy Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
The primary purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of single oral doses of PF-05175157 in healthy volunteers.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-05175157 | Small molecule | 10 mg | Oral |
| Subject | PF-05175157 | Small molecule | 30 mg | Oral |
| Subject | PF-05175157 | Small molecule | 100 mg | Oral |
| Subject | PF-05175157 | Small molecule | 300 mg | Oral |
| Subject | PF-05175157 | Small molecule | 600 mg | Oral |
| Subject | PF-05175157 | Small molecule | 800 mg | Oral |